Study Shows Paxlovid Can Safely Be Used to Reduce Risk of Severe COVID in People Who Are Pregnant

Johns Hopkins Medicine Awarded $10 Million to Optimize Antibiotic Therapy for Bacterial Infections

Johns Hopkins Experts Available for Interviews on This Year’s Flu Virus and Vaccine

Promising Anti-Cancer Drug Also May Function as COVID-19 Antiviral Therapy

Significant Boost in Rates of Type 2 Diabetes Among Children During COVID-19 Pandemic

Study Finds Genetic Method for Identifying Hundreds of Disease Agents ‘Promising’

Johns Hopkins Medicine-Led Consortium to Receive Up to $200 Million to Fight TB Globally

MEDIA ADVISORY: Johns Hopkins Health Policy Forum with Donna Shalala, Former Member of Congress and the 18th U.S. Secretary of Health and Human Services

Common Medical Tool May Delay Treatment of Nonwhite Patients with COVID-19

Why Breakthrough COVID? Antibodies Fighting Original Virus May Be Weaker Against Omicron